The Old and the New: successful vaccines of the 20th century and approaches to making vaccines for the important diseases of the 21st century

Gregory Poland, Alan Barrett

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Overall, the success of developing vaccines against acute diseases in the 20th century has laid the groundwork for vaccine development for chronic diseases in the 21st century. It is clear that we are still identifying the appropriate immunogens for inclusion in vaccines for chronic diseases and once identified our progress in enhancing the immune response is crucial for controlling these conditions either as prophylactic or therapeutic vaccines. We now enter a second 'golden age' of vaccinology in the enhanced understanding of common diseases, vaccine development against chronic noninfectious diseases, and in better integrating advances in biology, genomics, immunology, molecular biology, and virology.

Original languageEnglish (US)
Pages (from-to)305-307
Number of pages3
JournalCurrent Opinion in Immunology
Volume21
Issue number3
DOIs
StatePublished - Jun 2009

Fingerprint

Vaccines
Chronic Disease
Virology
Acute Disease
Genomics
Allergy and Immunology
Molecular Biology
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{a12a01cc2d484b41887b4cb099fb99d5,
title = "The Old and the New: successful vaccines of the 20th century and approaches to making vaccines for the important diseases of the 21st century",
abstract = "Overall, the success of developing vaccines against acute diseases in the 20th century has laid the groundwork for vaccine development for chronic diseases in the 21st century. It is clear that we are still identifying the appropriate immunogens for inclusion in vaccines for chronic diseases and once identified our progress in enhancing the immune response is crucial for controlling these conditions either as prophylactic or therapeutic vaccines. We now enter a second 'golden age' of vaccinology in the enhanced understanding of common diseases, vaccine development against chronic noninfectious diseases, and in better integrating advances in biology, genomics, immunology, molecular biology, and virology.",
author = "Gregory Poland and Alan Barrett",
year = "2009",
month = "6",
doi = "10.1016/j.coi.2009.05.014",
language = "English (US)",
volume = "21",
pages = "305--307",
journal = "Current Opinion in Immunology",
issn = "0952-7915",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - The Old and the New

T2 - successful vaccines of the 20th century and approaches to making vaccines for the important diseases of the 21st century

AU - Poland, Gregory

AU - Barrett, Alan

PY - 2009/6

Y1 - 2009/6

N2 - Overall, the success of developing vaccines against acute diseases in the 20th century has laid the groundwork for vaccine development for chronic diseases in the 21st century. It is clear that we are still identifying the appropriate immunogens for inclusion in vaccines for chronic diseases and once identified our progress in enhancing the immune response is crucial for controlling these conditions either as prophylactic or therapeutic vaccines. We now enter a second 'golden age' of vaccinology in the enhanced understanding of common diseases, vaccine development against chronic noninfectious diseases, and in better integrating advances in biology, genomics, immunology, molecular biology, and virology.

AB - Overall, the success of developing vaccines against acute diseases in the 20th century has laid the groundwork for vaccine development for chronic diseases in the 21st century. It is clear that we are still identifying the appropriate immunogens for inclusion in vaccines for chronic diseases and once identified our progress in enhancing the immune response is crucial for controlling these conditions either as prophylactic or therapeutic vaccines. We now enter a second 'golden age' of vaccinology in the enhanced understanding of common diseases, vaccine development against chronic noninfectious diseases, and in better integrating advances in biology, genomics, immunology, molecular biology, and virology.

UR - http://www.scopus.com/inward/record.url?scp=67049145543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049145543&partnerID=8YFLogxK

U2 - 10.1016/j.coi.2009.05.014

DO - 10.1016/j.coi.2009.05.014

M3 - Article

C2 - 19500965

AN - SCOPUS:67049145543

VL - 21

SP - 305

EP - 307

JO - Current Opinion in Immunology

JF - Current Opinion in Immunology

SN - 0952-7915

IS - 3

ER -